2-[1-fluoro-2-(4-methoxy-3-phenylmethoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
C22H26BFO4 — CID 171110275
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-fluoro-2-(4-methoxy-3-phenylmethoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-[1-fluoro-2-(4-methoxy-3-phenylmethoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (PubChem CID 171110275) has the molecular formula C22H26BFO4 and a molecular weight of 384.26 g/mol. Its IUPAC name is 2-[1-fluoro-2-(4-methoxy-3-phenylmethoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane.
Molecular Properties
| Compound Name | 2-[1-fluoro-2-(4-methoxy-3-phenylmethoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
|---|---|
| PubChem CID | 171110275 |
| Molecular Formula | C22H26BFO4 |
| Molecular Weight | 384.26 g/mol |
| Exact Mass | 384.19 |
| IUPAC Name | 2-[1-fluoro-2-(4-methoxy-3-phenylmethoxyphenyl)ethenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
| SMILES | COc1ccc(C=C(F)B2OC(C)(C)C(C)(C)O2)cc1OCc1ccccc1 |
| InChI | InChI=1S/C22H26BFO4/c1-21(2)22(3,4)28-23(27-21)20(24)14-17-11-12-18(25-5)19(13-17)26-15-16-9-7-6-8-10-16/h6-14H,15H2,1-5H3 |
| InChIKey | VNJILGBSKFPNNL-UHFFFAOYSA-N |
| XLogP | 5.22 |
| TPSA | 36.92 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.26 |
| LogP ≤ 5 | 5.22 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171110275 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.